Novo Nordisk's GLP-1 receptor agonist semaglutide ... and label extensions for both brands for cardiovascular risk reduction in certain high-risk patient groups. MASH is largely associated with ...

Wednesday marked a losing session on Wall Street, with the S&P 500 snapping its three-day win streak, as did the Nasdaq ...

Tensions in the Middle East shake Wall Street as healthcare stocks surge. Discover top gainers, Novo Nordisk's moves, and big pharma M&A updates.

LONDON (Reuters) -Drugmaker Novo Nordisk is once again Europe's largest company by market capitalisation, rising above German ...

Healthcare & Pharmaceuticalscategory· June 10, 2025 Novo Nordisk starts new CagriSema weightloss drug trial Novo Nordisk has launched a new late-stage trial for its experimental next-generation ...

Novo Nordisk has taken the bold step of buying three manufacturing facilities from contract development and manufacturing organisation Catalent as it tries to meet surging demand for its diabetes ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland ...

The LEO satellite market is projected to grow from USD 11.81 billion in 2025 to USD 20.69 billion by 2030, registering a CAGR ...